Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
HHS-OIG
Johnson and Johnson 2013 Settlement and Corporate Integrity Agreement
On November 4, 2013, the Department of Justice (DOJ) announced that Johnson & Johnson (J&J) and its pharmaceutical…
Physician-Owned Distributors: Reliance Medical Systems Files Suite…
In April of this year, we reported on a new Special Fraud Alert regarding physician-owned distributorships (PODs) issued by the…
FDLI 2013: Insights in Enforcement, Litigation & Compliance for…
The Food and Drug Law Institute (FDLI) recently held its annual Advertising & Promotion Conference, which included in-depth…
False Claims Act: External Auditor Moonlights as Whistle Blower
Over the last several years, we have covered a broad array of settlements, legal cases, and government investigations and…
Senate Committee on Homeland Security and Governmental Affairs Hearing:…
Gary Cantrell, Deputy Inspector General for Investigations, and Stuart Wright, Deputy Inspector General for Evaluation and…
Summary of Recent Settlements Novartis, Amgen and Boehringer Ingelheim
The healthcare fraud settlements just keep rolling in. Recently, federal healthcare enforcement authorities settled several cases…
HHS OIG: Hospital Compliance Programs
The Office of Inspector General (OIG) for the U.S. Department of Health and Human services (HHS) recently did a podcast on…
ISTA Settlement Includes Divestiture and Debarment
In what has been one of the less prominent drug-settlements in recent times, the federal government recently entered…
CMS Proposes Increased Incentives for Information on Misuse
The Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that would increase incentives for people to report…
HHS OIG Reports Small Percentage of Prescribers May be Overutilizing Part D…
Recently we reported that ProPublica had launched a new effort known as "Prescriber Checkup", which allows anyone with internet…